4.5 Article

High DNA Oxidative Damage in Systemic Sclerosis

期刊

JOURNAL OF RHEUMATOLOGY
卷 37, 期 12, 页码 2540-2547

出版社

J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.100398

关键词

SYSTEMIC SCLEROSIS; OXIDATIVE STRESS; OXIDATIVE DNA DAMAGE; LIPID PEROXIDATION

向作者/读者索取更多资源

Objective. Several lines of evidence suggest that the generation of reactive oxygen species (ROS) is of major importance in the pathogenesis of SSc. Protein and lipid damage have previously been demonstrated, but scarce data are available on oxidative damage to DNA. In patients with SSc, we evaluated levels of 8-hydroxy-2'-deoxyguanosine (8-oxodG), the main validated biomarker of endogenous oxidative damage to DNA, compared to levels of F2-isoprostane, a product of free radical-mediated peroxidation of arachidonic acid. Methods. Urinary levels of 8-oxodG and 8-isoprostaglandin-F-2 alpha (8-iso-PGF(2 alpha) were determined by competitive ELISA method in consecutive SSc patients and controls matched for age and sex. Results. We included 80 unrelated SSc patients (72 women, mean age 56 +/- 11 yrs) and 39 controls (33 women, mean age 64 +/- 8 yrs). Urinary levels of 8-oxodG/creat and 8-iso-PGF(2 alpha)/creat in SSc patients were found to be higher than in controls (6.5 ng/mg vs 3.7 ng/mg, p = 0.0001; and 11.4 ng/mg vs 4.2 ng/mg, p <0.0001). In multivariate analysis, 8-oxodG levels were associated with the presence of pulmonary fibrosis on computerized tomography scan, decreased forced vital capacity, and decreased DLCO/alveolar volume. In patients with the diffuse cutaneous subset, a modified Rodnan skin score > 14 was independently associated with 8-oxodG levels. In SSc, 8-oxodG and 8-iso-PGF(2 alpha) values were correlated (r = 0.32; p = 0.005). Conclusion. Our study confirmed marked oxidative stress in SSc. We also found increased values of 8-oxodG in SSc patients and a relevant association with a fibrotic phenotype. The predictive value of this marker and its potential influence on fibrotic disturbances remain to be determined. (First Release Sept 15 2010; J Rheumatol 2010;37:2540-7; doi:10.3899/jrheum.100398)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Rheumatology

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Jerome Avouac, Paolo Airo, Nicolas Carlier, Marco Matucci-Cerinic, Yannick Allanore

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Rheumatology

Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetes

Jerome Avouac, Muriel Elhai, Marine Forien, Jeremie Sellam, Florent Eymard, Anna Molto, Frederic Banal, Joel Damiano, Philippe Dieude, Etienne Larger, Yannick Allanore

Summary: Patients with RA or OA have severe T2D with insulin resistance associated with inflammation. Insulin resistance is higher in RA compared to OA patients and HbA1c levels are independently associated with bone erosions. Treatment with TNF-alpha inhibitors is associated with increased insulin sensitivity.

RHEUMATOLOGY (2021)

Article Rheumatology

Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis

Jerome Avouac, Sonia Pezet, Eloise Vandebeuque, Cindy Orvain, Virginie Gonzalez, Gregory Marin, Gael Mouterde, Claire Daien, Yannick Allanore

Summary: Semaphorins were found to be potential biomarkers and therapeutic candidates in the pathogenesis of rheumatoid arthritis, with confirmed overexpression in ECs, synovial vessels, and serum, and correlation with validated markers of inflammation and angiogenesis. Their presence, especially SEMA4A, could identify patients with residual disease activity even in low disease activity or RA remission.

ARTHRITIS & RHEUMATOLOGY (2021)

Review Rheumatology

Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?

Cindy Orvain, Morgane Boulch, Philippe Bousso, Yannick Allanore, Jerome Avouac

Summary: CAR-T cell therapy targets tumor antigens with high specificity, demonstrating efficacy in managing B cell malignancies. The technology has potential applications in autoimmune rheumatic diseases, with ongoing research exploring its use and impact in this area.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients

Jerome Avouac, Corinne Miceli-Richard, Alice Combier, Alexia Steelandt, Olivier Fogel, Alice Andree Mariaggi, Jean-Francois Meritet, Flore Rozenberg, Anna Molto, Yannick Allanore

Summary: This study aimed to identify factors influencing the humoral response to COVID-19 vaccination in RTX-treated patients. The results showed that B cell depletion was the main contributing factor to the antibody response in these patients, and monitoring CD19 levels may help determine the optimal timing for vaccination.

RHEUMATOLOGY (2022)

Review Rheumatology

Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study

Michael Hughes, Elisabetta Zanatta, Robert D. Sandler, Jerome Avouac, Yannick Allanore

Summary: This study found that despite the heterogeneity and scarcity of vascular disease in SSc, there have been significant improvements in various vascular complications over time, leading to improved survival rates for patients.

RHEUMATOLOGY (2022)

Article Rheumatology

Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?

Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, Valeria Riccieri, Yannick Allanore, Christopher P. Denton, Eric Hachulla, Francesca Ingegnoli, Ellen Deschepper, Jerome Avouac, Suzana Jordan, David Launay, Karin Melsens, Carmen Pizzorni, Alberto Sulli, Massimiliano Vasile, Ariane L. Herrick, Vanessa Smith

Summary: Nailfold videocapillaroscopy (NVC) may be a promising biomarker in SSc, as it is associated with novel severe organ involvement/progression.

RHEUMATOLOGY (2022)

Letter Rheumatology

Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection

Jerome Avouac, Roba Ghossan, Omar Al Tabaa, Alice Combier, Alexia Steelandt, Marion Thomas, Olivier Fogel, Alice Andree Mariaggi, Jean-Francois Meritet, Flore Rozenberg, Anna Molto, Corinne Miceli-Richard, Yannick Allanore

RHEUMATOLOGY (2022)

Article Rheumatology

Evaluation of Patients With Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 Pandemic

Jerome Avouac, Anna Molto, Camelia Frantz, Sarah Wanono, Elise Descamps, Olivier Fogel, Alice Combier, Lucile Poiroux, Corinne Miceli-Richard, Yannick Allanore

Summary: This study identified patient-reported RA flares and increased CRP values as important indicators in teleconsultation, which are associated with therapeutic modification and the need for a face-to-face consultation.

JOURNAL OF RHEUMATOLOGY (2022)

Article Pharmacology & Pharmacy

JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study

Amandine Gouverneur, Jerome Avouac, Clement Prati, Jean-Luc Cracowski, Thierry Schaeverbeke, Antoine Pariente, Marie-Elise Truchetet

Summary: The use of baricitinib and tofacitinib is associated with an increased risk of venous thromboembolic events (VTE) and arterial thromboembolic events (ATE).

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Editorial Material Rheumatology

Importance of SARS-CoV-2 Spike Antibodies and B Cell Reconstitution to Optimize the Prevention Strategy of COVID-19

Marion Thomas, Jerome Avouac

JOURNAL OF RHEUMATOLOGY (2023)

Review Rheumatology

Busting the myth of methotrexate chronic hepatotoxicity

Vincent Di Martino, Delphine Weil Verhoeven, Frank Verhoeven, Francois Aubin, Jerome Avouac, Lucine Vuitton, Frederic Liote, Thierry Thevenot, Daniel Wendling

Summary: Methotrexate is an important treatment for inflammatory rheumatic diseases, especially rheumatoid arthritis. Liver toxicity is a concern for long-term methotrexate therapy, particularly in patients with non-alcoholic fatty liver disease (NAFLD). Understanding the mechanisms of hepatotoxicity and liver fibrosis is crucial for pretreatment screening and long-term monitoring in patients with chronic liver disease.

NATURE REVIEWS RHEUMATOLOGY (2023)

Article Rheumatology

Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis

Jerome Avouac, Anne Cauvet, Cindy Orvain, Morgane Boulch, Francoise Tilotta, Ly Tu, Raphael Thuillet, Mina Ottaviani, Christophe Guignabert, Philippe Bousso, Yannick Allanore

Summary: This study aimed to investigate the efficacy of two B cell depletion strategies, including CD19-targeted CAR T cells, in a preclinical model of severe lung damages observed in systemic sclerosis. The study evaluated B cell depletion strategies in Fra-2 Tg mice. The results showed that CD19-targeted CAR-T cells in combination with anti-CD20 monoclonal antibody achieved deeper B cell depletion compared to anti-CD20 monoclonal antibody alone in both peripheral blood and lesional lungs of Fra-2 Tg mice. However, CAR-T cell infusion worsened the clinical score and increased mortality in Fra-2 Tg mice. CAR-T cell infusion also resulted in increased lung collagen content, histological fibrosis score, and right ventricular systolic pressure. CAR-T cells accumulated in lesional lungs and promoted T activation and inflammatory cytokine production. On the other hand, treatment with anti-CD20 monoclonal antibody alone had no impact on lung inflammation-driven fibrosis and pulmonary hypertension.

ARTHRITIS & RHEUMATOLOGY (2023)

Letter Rheumatology

Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice

Paola Vidal-Montal, Marion Thomas, Alice Combier, Alexia Steelandt, Corinne Miceli-Richard, Anna Molto, Javier Narvaez, Joan Miquel Nolla, Yannick Allanore, Jerome Avouac

JOINT BONE SPINE (2023)

暂无数据